The National Conference on Unity for Growth – A Collective March Towards Viksit Bharat, held on 03rd July 2025 at Bharat Mandapam, proved to be a groundbreaking and thought-provoking forum that united leaders from across the nation. Organized by Brand Vista Consulting, this landmark event brought together prominent policymakers, business leaders, social innovators, and youth change agents who collectively reinforced a shared vision for a developed, inclusive, and self-reliant India by 2047.
The theme of the conference, “Unity for Growth”, was powerfully reflected in the message shared by the organizers. Grounded in the spirit of “VasudhaivaKutumbakam – The World is One Family,” the conference emphasized collaboration over competition, encouraging industries, institutions, and individuals to embrace a more humanitarian and cooperative approach to nation-building.
One of the eminent participants and winner of the India’s Iconic Brand & Leader 2024-25 was Dr. Deepak Shenoy, Founder & Managing Director, Medec Dragon.
In the world of pharmaceuticals, Medec Medicare Limited stands out as an epitome of innovation, integrity, and global impact. Under the visionary leadership of Dr. Deepak Shenoy, the company has rapidly become a preferred partner for both innovator and generic pharmaceutical companies worldwide. Medec’s commitment to quality, sustainability, and customer-centric solutions has not only transformed its business trajectory but also contributed significantly to global healthcare advancements.
Visionary Leadership and Strategic Growth
The visionary leadership of Dr. Deepak Shenoy, Vice Chairman & Managing of Medec Medicare Limited have propelled the company to new heights. His expertise spans financial management, team building, mergers and acquisitions. With over 15 years of experience in the pharmaceutical sector and a proven track record in marketing, analytics and operations, Dr. Shenoy has masterfully guided Medec’s expansion into emerging markets. His accolades, including an Honorary Doctorate from Dr. APJ Abdul Kalam University and Honorary Professorship from the University of California – Berkeley, underscore his dedication to pharmaceutical exports and industry excellence. Dr. Shenoy’s leadership style is characterized by an ability to identify growth opportunities and foster a culture of ethical business conduct, innovation, and stakeholder confidence.
Comprehensive Contract Manufacturing Solutions
Medec Medicare Limited specializes in providing fully integrated third-party contract manufacturing and development solutions. The company operates under a loan license arrangement, undertaking the manufacturing of pharmaceutical intermediates and advanced intermediates of APIs across a wide range of therapeutic categories. With WHO-GMP certified facilities, Medec has established a robust presence in over 70 countries, including key markets in Japan, APAC, the Middle East, Africa, Europe, and the Americas. Their asset-light business model allows for flexibility and scalability, catering to niche segments such as oncology, cardiovascular, diabetes management, anti-malarials, antibiotics, antivirals, and pain management.
Commitment to Sustainability and Innovation
Sustainability is at the core of Medec’s operations. The company leverages its strong intellectual property portfolio and highly skilled technical team to deliver high-quality products that meet global standards. Medec partners with biotech-based manufacturers who adhere to stringent regulatory compliance and sustainable practices, including biocatalytic conversions, flow chemistry, and energy-efficient processes. This commitment to sustainability is complemented by a focus on research and development, with continuous investment in future-ready technologies and innovative growth strategies. The result is a resilient supply chain, preferential raw material allocations, and a robust logistics network that ensures timely delivery of quality products worldwide.
Recognition and Future Outlook
Medec Medicare Limited’s excellence in corporate governance was recognized with the “Most Promising Company in Corporate Governance 2023” award at ASSOCHAM’s national seminar. This accolade reflects the company’s unwavering dedication to ethical practices, risk mitigation, and stakeholder value creation. As the Indian API market continues to grow, Medec is well-positioned to capitalize on emerging opportunities, driven by its technical excellence, customer-centric approach, and commitment to making human life safer and disease-free. With a strong foundation and forward-looking vision, Medec Medicare Limited is poised for continued success and leadership in the global pharmaceutical industry.
For media inquiries, interviews, or follow-ups, please contact, Brand Vista Consulting Team – Email: vp@brandvistaconsulting.com, Website: www.brandvistaconsulting.com
